To cite this paper use one of the standards below:
Fused heterocycles have attracted considerable interest because of their diverse biological activities and their importance as versatile scaffolds in organic synthesis1. Among these, pyranocoumarins are particularly valuable as key intermediates for the synthesis of a wide range of biologically active compounds2. As fused dihydropyran–chromene derivatives, pyranocoumarins exhibit numerous pharmacological properties, including anti-HIV, antitumor, anticancer, antibacterial, and anti-inflammatory activities3. Given the broad spectrum of biological activities associated with the pyranocoumarin framework, this study focuses on the synthesis of novel fused dihydropyran–pyranocoumarin derivatives through one-pot multicomponent reactions (MCRs). The synthesized compounds were characterized by high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy. Their biological potential will be investigated by evaluating their inhibitory activities against α-amylase and α-glucosidase, as well as their in vitro cytotoxicity against tumor cell lines and intracellular amastigotes of Leishmania amazonensis and Trypanosoma cruzi.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper